This suggests that presynaptic dopamine dysregulation is a potential mechanism for the increased rates of psychotic disorders seen in the original DISC1 families and DISC1 variant carriers, and identifies a number of potential therapeutic targets for treating or even preventing schizophrenia based on the DISC1 pathway. Here, DISC1 is linked to schizophrenia.